您当前的位置:
首页 >
文章列表页 >
Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]
更新时间:2023-05-16
    • Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]

    • Genes & Diseases   Vol. 10, Issue 2, (2023)
    • 作者机构:

      1. School of Laboratory Medicine, Chongqing Medical University,Chongqing,China,400016

      2. Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400042

    • DOI:10.1016/j.gendis.2023.02.002    

      CLC:
    • Published:2023,

      Published Online:1 March 2023,

    扫 描 看 全 文

  • Chunmei Yang, Lulu Zhang, Huakun Huang, et al. Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]. [J]. Genes & Diseases 10(2).(2023) DOI: 10.1016/j.gendis.2023.02.002.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0